| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,399 |
1,100 |
$92K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,252 |
991 |
$19K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
389 |
365 |
$14K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
278 |
239 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
86 |
71 |
$3K |
| 99215 |
Prolong outpt/office vis |
50 |
45 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
89 |
46 |
$2K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
24 |
16 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
13 |
13 |
$1K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
20 |
16 |
$728.87 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
19 |
13 |
$607.35 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
16 |
12 |
$232.00 |